[DOI] [PMC free article] [PubMed] [Google Scholar] Polidori MC, Nelles G
Though the effectiveness of this new class of drugs has led to an outsize focus on GLP-1, weight-loss resistance is really much bigger than any one hormone, she notes
For those participating in a clinical trial, all adverse effects even those that seem minor should be reported to the trial team as part of the pharmacovigilance process
Time for returning to baseline LDL-C level might be slightly shorter using MEDI4166, around 10 and 14 days following a 1 mg/kg iv dose of MEDI4166 and anti-PCSK9 J16 mAb 42 respectively
Accelerated demand after Mounjaros launch Even before Mounjaros momentous debut, Ozempic demonstrated notable HbA1c reductions and weight loss results, and demand for GLP-1s grew at a steady rate (compound monthly growth of 2% from January 2020 to May 2021)
The most challenging transition for most people is the jump from 0.25 mg to 0.5 mg because it is the first time the body encounters a dose that significantly affects gastric emptying
